Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finegood, D. T.
Right arrow Articles by Vranic, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finegood, D. T.
Right arrow Articles by Vranic, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 37, Issue 8 1025-1034, Copyright © 1988 by American Diabetes Association


ARTICLES

Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps

DT Finegood, RN Bergman and M Vranic
Department of Physiology, University of Toronto, Ontario, Canada.

We previously demonstrated that conventional tracer methods applied to euglycemic-hyperinsulinemic glucose clamps result in substantially negative estimates for the rate of endogenous glucose production, particularly during the first half of 180-min clamps. We also showed that addition of tracer to the exogenous glucose infusate resulted in nonnegative endogenous glucose production (Ra) estimates. In this study, we investigated the underlying cause of negative estimates of Ra from conventional clamp/tracer methods and the reason for the difference in estimates when tracer is added to the exogenous glucose infusate. We performed euglycemic-hyperinsulinemic (300-microU/ml) clamps in normal dogs without (cold GINF protocol, n = 6) or with (hot GINF protocol, n = 6) tracer (D-[3-3H]glucose) added to the exogenous glucose infusate. In the hot GINF protocol, sufficient tracer was added to the exogenous glucose infusate such that arterial plasma specific activity (SAa) did not change from basal through the clamp period (P greater than .05). In the cold GINF studies, plasma SAa fell 81 +/- 2% from the basal level by the 3rd h of clamping. We observed a significant, transient, positive venous-arterial difference in specific activity (SAv-SAa difference) during the cold GINF studies. The SAv-SAa difference reached a peak of 27 +/- 6% at 30 min and diminished to a plateau of 7 +/- 1% between 70 and 180 min. We also observed a positive but constant SAv-SAa difference (4.6 +/- 0.2% between 10 and 180 min) during the hot GINF studies. The observations of a difference between hot and cold GINF endogenous Ra estimates and a positive but transient SAv-SAa difference during the cold GINF studies are consistent with the interpretation that a portion of the underestimation of Ra is due to insufficient mixing of endogenous and exogenous glucose for the one-compartment, fixed-pool volume model to be applicable. Alternatively, our results suggest that the one-compartment, fixed-pool volume model of glucose kinetics is insufficient to account for the complex dynamics of labeled and unlabeled glucose during euglycemic-hyperinsulinemic clamps. Improved mixing through addition of tracer to the exogenous glucose infusate or improved modeling by allowing for a variable-pool volume appears to improve the accuracy of the tracer methods; however, these approaches remain to be validated. The constant positive SAv-SAa difference observed during the hot GINF studies is consistent with the interpretation that an additional contributor to underestimation of endogenous Ra is apparent isotope discrimination.(ABSTRACT TRUNCATED AT 400 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
I. R. Lanza, D. K. Short, K. R. Short, S. Raghavakaimal, R. Basu, M. J. Joyner, J. P. McConnell, and K. S. Nair
Endurance Exercise as a Countermeasure for Aging
Diabetes, November 1, 2008; 57(11): 2933 - 2942.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
E. Park, V. Wong, X. Guan, A. I Oprescu, and A. Giacca
Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo
J. Endocrinol., November 1, 2007; 195(2): 323 - 331.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. C. Carpentier, F. Frisch, P. Brassard, F. Lavoie, A. Bourbonnais, D. Cyr, R. Giguere, and J.-P. Baillargeon
Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E693 - E701.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Ozawa, M. Miyazaki, M. Matsuhisa, K. Takano, Y. Nakatani, M. Hatazaki, T. Tamatani, K. Yamagata, J.-i. Miyagawa, Y. Kitao, et al.
The Endoplasmic Reticulum Chaperone Improves Insulin Resistance in Type 2 Diabetes
Diabetes, March 1, 2005; 54(3): 657 - 663.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Thorell, O. Rooyackers, P. Myrenfors, M. Soop, J. Nygren, and O. H. Ljungqvist
Intensive Insulin Treatment in Critically Ill Trauma Patients Normalizes Glucose by Reducing Endogenous Glucose Production
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5382 - 5386.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Basu, A. Basu, C. M. Johnson, W. F. Schwenk, and R. A. Rizza
Insulin Dose-Response Curves for Stimulation of Splanchnic Glucose Uptake and Suppression of Endogenous Glucose Production Differ in Nondiabetic Humans and Are Abnormal in People With Type 2 Diabetes
Diabetes, August 1, 2004; 53(8): 2042 - 2050.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. C. Camacho, D. B. Lacy, F. D. James, R. H. Coker, and D. H. Wasserman
Hepatic glucose autoregulation: responses to small, non-insulin-induced changes in arterial glucose
Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E269 - E274.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. C. Camacho, R. R. Pencek, D. B. Lacy, F. D. James, and D. H. Wasserman
Suppression of Endogenous Glucose Production by Mild Hyperinsulinemia During Exercise Is Determined Predominantly by Portal Venous Insulin
Diabetes, February 1, 2004; 53(2): 285 - 293.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
H. L. Simpson, N. C. Jackson, F. Shojaee-Moradie, R. H. Jones, D. L. Russell-Jones, P. H. Sonksen, D. B. Dunger, and A. M. Umpleby
Insulin-Like Growth Factor I Has a Direct Effect on Glucose and Protein Metabolism, But No Effect on Lipid Metabolism in Type 1 Diabetes
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 425 - 432.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Vella, A. S. Reed, N. Charkoudian, P. Shah, R. Basu, A. Basu, M. J. Joyner, and R. A. Rizza
Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles
Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E25 - E30.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Basu, B. Di Camillo, G. Toffolo, A. Basu, P. Shah, A. Vella, R. Rizza, and C. Cobelli
Use of a novel triple-tracer approach to assess postprandial glucose metabolism
Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E55 - E69.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Gupta, H. Sandhu, T. Goh, K. Shah, S. R. Wiesenthal, H. Yoshii, V. Chong, T. K. T. Lam, C. A. Haber, W. Williams, et al.
Insulin inhibits glucose production by a direct effect in diabetic depancreatized dogs during euglycemia
Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1002 - E1007.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Musi, M. F. Hirshman, J. Nygren, M. Svanfeldt, P. Bavenholm, O. Rooyackers, G. Zhou, J. M. Williamson, O. Ljunqvist, S. Efendic, et al.
Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes
Diabetes, July 1, 2002; 51(7): 2074 - 2081.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Endocr. Rev., April 1, 2002; 23(2): 201 - 229.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. S. Meneilly, C. H.S. McIntosh, R. A. Pederson, J. F. Habener, R. Gingerich, J. M. Egan, D. T. Finegood, and D. Elahi
Effect of Glucagon-Like Peptide 1 on Non-Insulin-Mediated Glucose Uptake in the Elderly Patient With Diabetes
Diabetes Care, November 1, 2001; 24(11): 1951 - 1956.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. S. Edgerton, S. Cardin, M. Emshwiller, D. Neal, V. Chandramouli, W. C. Schumann, B. R. Landau, L. Rossetti, and A. D. Cherrington
Small Increases in Insulin Inhibit Hepatic Glucose Production Solely Caused by an Effect on Glycogen Metabolism
Diabetes, August 1, 2001; 50(8): 1872 - 1882.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Basu, R. Basu, P. Shah, A. Vella, C. M. Johnson, M. Jensen, K. S. Nair, W. F. Schwenk, and R. A. Rizza
Type 2 Diabetes Impairs Splanchnic Uptake of Glucose but Does Not Alter Intestinal Glucose Absorption During Enteral Glucose Feeding: Additional Evidence for a Defect in Hepatic Glucokinase Activity
Diabetes, June 1, 2001; 50(6): 1351 - 1362.
[Abstract] [Full Text]


Home page
DiabetesHome page
A. Carpentier, B. W. Patterson, K. D. Uffelman, A. Giacca, M. Vranic, M. S. Cattral, and G. F. Lewis
The Effect of Systemic Versus Portal Insulin Delivery in Pancreas Transplantation on Insulin Action and VLDL Metabolism
Diabetes, June 1, 2001; 50(6): 1402 - 1413.
[Abstract] [Full Text]


Home page
DiabetesHome page
P. N. Båvenholm, J. Pigon, C.-G. Östenson, and S. Efendic
Insulin Sensitivity of Suppression of Endogenous Glucose Production Is the Single Most Important Determinant of Glucose Tolerance
Diabetes, June 1, 2001; 50(6): 1449 - 1454.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Soop, J. Nygren, P. Myrenfors, A. Thorell, and O. Ljungqvist
Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance
Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E576 - E583.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. S. Thresher, D. A. Podolin, Y. Wei, R. S. Mazzeo, and M. J. Pagliassotti
Comparison of the effects of sucrose and fructose on insulin action and glucose tolerance
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1334 - R1340.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. Gastaldelli, A. R. Coggan, and R. R. Wolfe
Assessment of methods for improving tracer estimation of non-steady-state rate of appearance
J Appl Physiol, November 1, 1999; 87(5): 1813 - 1822.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. Bergeron, M. Kjaer, L. Simonsen, J. Bulow, and H. Galbo
Glucose production during exercise in humans: a-hv balance and isotopic-tracer measurements compared
J Appl Physiol, July 1, 1999; 87(1): 111 - 115.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Thorell, J. Nygren, M. F. Hirshman, T. Hayashi, K. S. Nair, E. S. Horton, L. J. Goodyear, and O. Ljungqvist
Surgery-induced insulin resistance in human patients: relation to glucose transport and utilization
Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E754 - E761.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. F. Lewis, A. Carpentier, D. Bilinski, A. Giacca, and M. Vranic
Counterregulatory Response to Hypoglycemia Differs According to the Insulin Delivery Route, But Does Not Affect Glucose Production in Normal Humans
J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1037 - 1046.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. W. Coppack, M. Persson, R. L. Judd, and J. M. Miles
Glycerol and nonesterified fatty acid metabolism in human muscle and adipose tissue in vivo
Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E233 - E240.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Cersosimo, P. Garlick, and J. Ferretti
Insulin regulation of renal glucose metabolism in humans
Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E78 - E84.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. D. Wise, M. F. Nielsen, P. E. Cryer, and R. A. Rizza
Overnight Normalization of Glucose Concentrations Improves Hepatic But Not Extrahepatic Insulin Action in Subjects with Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2461 - 2469.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. O. Nygren, A. Thorell, M. Soop, S. Efendic, K. Brismar, F. Karpe, K. S. Nair, and O. Ljungqvist
Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery
Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E140 - E148.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. F. Lewis, M. Vranic, and A. Giacca
Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans
Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E177 - E186.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. H. McCall, S. R. Wiesenthal, Z. Q. Shi, K. Polonsky, and A. Giacca
Insulin acutely suppresses glucose production by both peripheral and hepatic effects in normal dogs
Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E346 - E356.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J.-A. Simoneau and D. E. Kelley
Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM
J Appl Physiol, July 1, 1997; 83(1): 166 - 171.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Giacca, S. J. Fisher, R. H. McCall, Z. Q. Shi, and M. Vranic
Direct and Indirect Effects of Insulin in Suppressing Glucose Production in Depancreatized Dogs: Role of Glucagon
Endocrinology, March 1, 1997; 138(3): 999 - 1007.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1988 by the American Diabetes Association.